SYK and retinoblastoma: In our cohort, the majority of RB tumors demonstrated MYCN and SYK promoter DNA hypomethylation (associated with gene activation); this profile was similarly identified in all AH samples as compared to apparently normal retinal tissues (Fig. 3C), suggesting that these targets can be detected via AH methylation profiling.